scholarly article | Q13442814 |
P50 | author | Robert P Igo | Q92784819 |
Kristin N Meyer | Q96127926 | ||
Gloria E Sarto | Q114375000 | ||
Barbara J Truitt | Q114447141 | ||
Chitra K Karki | Q114723333 | ||
Karen M Gehrs | Q58411078 | ||
Sudha Iyengar | Q64008607 | ||
Lesley F Tinker | Q85643662 | ||
Paul S Bernstein | Q88167571 | ||
Erin S LeBlanc | Q89239956 | ||
Amy E Millen | Q90397187 | ||
P2093 | author name string | Michael Klein | |
Zhe Liu | |||
Elizabeth J Johnson | |||
Corinne D Engelman | |||
Robert Wallace | |||
John Paul SanGiovanni | |||
Julie A Mares | |||
Barbara Blodi | |||
Jennifer Robinson | |||
P2860 | cites work | Population structure and eigenanalysis | Q21145248 |
A mitochondrial enzyme degrades carotenoids and protects against oxidative stress | Q24308718 | ||
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration | Q24622351 | ||
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) | Q24622766 | ||
PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. | Q51386596 | ||
Apolipoprotein E Gene Associations in Age-related Macular Degeneration: The Melbourne Collaborative Cohort Study | Q57100196 | ||
Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration | Q57254341 | ||
Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS) | Q63344335 | ||
Reducing the Genetic Risk of Age-Related Macular Degeneration With Dietary Antioxidants, Zinc, and ω-3 Fatty Acids | Q64461561 | ||
Preliminary identification of the human macular pigment | Q69790666 | ||
Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables | Q71611064 | ||
Distributions of carotenoids and alpha-tocopherol among lipoproteins do not change when human plasma is incubated in vitro | Q71749317 | ||
Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study | Q73570510 | ||
Dietary modification of human macular pigment density | Q73671816 | ||
Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice | Q73990815 | ||
Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study | Q74805233 | ||
Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant-antioxidant imbalance in healthy subjects | Q78175112 | ||
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative | Q79340995 | ||
The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter | Q80853945 | ||
The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation | Q81247711 | ||
CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism in mice | Q81250317 | ||
The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs | Q83154450 | ||
Evaluation of serum lipid concentrations and genetic variants at high-density lipoprotein metabolism loci and TIMP3 in age-related macular degeneration | Q84196756 | ||
Lutein supplementation reduces plasma lipid peroxidation and C-reactive protein in healthy nonsmokers | Q86093278 | ||
Principal components analysis corrects for stratification in genome-wide association studies | Q27860975 | ||
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration | Q28190470 | ||
The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study | Q28248143 | ||
Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration | Q28290149 | ||
Carotenoids in the human macula and whole retina | Q28609504 | ||
Seven new loci associated with age-related macular degeneration | Q29416998 | ||
Quality control and quality assurance in genotypic data for genome-wide association studies | Q30498925 | ||
Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients | Q30858951 | ||
Influence of lutein supplementation on macular pigment, assessed with two objective techniques. | Q30929610 | ||
Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study | Q31143690 | ||
Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density | Q31389893 | ||
Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population | Q31830839 | ||
Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. | Q31951685 | ||
Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey | Q32066253 | ||
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization | Q33302396 | ||
Discerning the ancestry of European Americans in genetic association studies | Q33315561 | ||
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration | Q33508828 | ||
A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries). | Q33528280 | ||
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23 | Q33613367 | ||
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration | Q33634096 | ||
Genome-wide association study identifies variants at the IL18-BCO2 locus associated with interleukin-18 levels | Q33740363 | ||
Nutritional manipulation of primate retinas, V: effects of lutein, zeaxanthin, and n-3 fatty acids on retinal sensitivity to blue-light-induced damage | Q33796324 | ||
A genetic risk score combining ten psoriasis risk loci improves disease prediction | Q33894914 | ||
Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome | Q33953350 | ||
The role of oxidative stress in the pathogenesis of age-related macular degeneration. | Q34060719 | ||
Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study | Q34108927 | ||
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study | Q34138412 | ||
Long-chain and very long-chain polyunsaturated fatty acids in ocular aging and age-related macular degeneration | Q34188018 | ||
Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. | Q34278325 | ||
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group | Q34323879 | ||
Distribution of lutein and zeaxanthin stereoisomers in the human retina | Q34428109 | ||
n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases | Q34569101 | ||
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin | Q34627818 | ||
Single nucleotide polymorphisms upstream from the β-carotene 15,15'-monoxygenase gene influence provitamin A conversion efficiency in female volunteers | Q34633920 | ||
A2E and blue light in the retina: the paradigm of age-related macular degeneration | Q34658953 | ||
Prediction of individual genetic risk to disease from genome-wide association studies | Q34676890 | ||
The effect of lutein supplementation on blood plasma levels of complement factor D, C5a and C3d. | Q34979785 | ||
Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins | Q35056603 | ||
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies | Q35552553 | ||
Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study | Q35658968 | ||
The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study | Q36136223 | ||
The inflammation highway: metabolism accelerates inflammatory traffic in obesity | Q36174974 | ||
The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: promise of molecular genetics for guiding mechanistic and translational research in the field. | Q36317120 | ||
Carotenoid actions and their relation to health and disease | Q36323052 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism | Q36745022 | ||
Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study | Q36766616 | ||
Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration | Q36825090 | ||
Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults | Q36843378 | ||
Delta6-desaturase (FADS2) deficiency unveils the role of omega3- and omega6-polyunsaturated fatty acids | Q36862651 | ||
Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations | Q37069102 | ||
Lutein and zeaxanthin supplementation reduces photooxidative damage and modulates the expression of inflammation-related genes in retinal pigment epithelial cells | Q37098578 | ||
Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy | Q37134473 | ||
Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study | Q37156081 | ||
Genetic ablation of carotene oxygenases and consumption of lycopene or tomato powder diets modulate carotenoid and lipid metabolism in mice | Q37246324 | ||
New roles of HDL in inflammation and hematopoiesis | Q37314961 | ||
Two carotenoid oxygenases contribute to mammalian provitamin A metabolism | Q37333819 | ||
Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids | Q37625442 | ||
Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium | Q37702757 | ||
Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism | Q37736472 | ||
Marked HDL deficiency and premature coronary heart disease. | Q37771219 | ||
Proteins involved in uptake, intracellular transport and basolateral secretion of fat-soluble vitamins and carotenoids by mammalian enterocytes | Q37901804 | ||
Genetic variations involved in interindividual variability in carotenoid status. | Q37940438 | ||
Importance of β,β-carotene 15,15'-monooxygenase 1 (BCMO1) and β,β-carotene 9',10'-dioxygenase 2 (BCDO2) in nutrition and health | Q37965458 | ||
Sunlight exposure, antioxidants, and age-related macular degeneration | Q39006183 | ||
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration | Q39575237 | ||
Purification and partial characterization of a lutein-binding protein from human retina | Q42025555 | ||
Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). | Q42470830 | ||
Patients with Sjögren-Larsson syndrome lack macular pigment. | Q43158883 | ||
Apolipoprotein E genotype is associated with macular pigment optical density | Q43182517 | ||
Genetic variation in the beta, beta-carotene-9', 10'-dioxygenase gene and association with fat colour in bovine adipose tissue and milk | Q43227945 | ||
Macular pigment in donor eyes with and without AMD: a case-control study. | Q43514008 | ||
The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. | Q43796210 | ||
Neovascular age-related macular degeneration and its relationship to antioxidant intake | Q44110946 | ||
Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. | Q44168282 | ||
Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study | Q44212321 | ||
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation | Q44386863 | ||
Lutein and zeaxanthin status and risk of age-related macular degeneration. | Q44453108 | ||
Effects of omega-3 fatty acid supplementation and exercise on low-density lipoprotein and high-density lipoprotein subfractions | Q44911463 | ||
Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study | Q44925974 | ||
Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium | Q45028017 | ||
Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. | Q45050501 | ||
Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. | Q46023211 | ||
The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans | Q46175085 | ||
Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe | Q46715258 | ||
Heritability of macular pigment: a twin study | Q46816863 | ||
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. | Q50268024 | ||
Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. | Q50474439 | ||
Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. | Q50478568 | ||
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. | Q50495142 | ||
Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein. | Q50497118 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
macular degeneration | Q27429789 | ||
P304 | page(s) | 587-599 | |
P577 | publication date | 2014-01-29 | |
P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
P1476 | title | Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS). | |
P478 | volume | 55 |
Q28512836 | A genetic dissection of intestinal fat-soluble vitamin and carotenoid absorption |
Q26823002 | Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions |
Q26801165 | Asparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis) |
Q92188405 | Associations Between the Apolipoprotein E ε4 Allele and Reduced Serum Levels of High Density Lipoprotein a Cognitively Normal Aging Han Chinese Population |
Q34185581 | Bioavailability of AREDS1 micronutrients from softgel capsules and tablets: a pilot study |
Q37686531 | Brain xanthophyll content and exploratory gene expression analysis: subspecies differences in rhesus macaque |
Q28551885 | Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis |
Q45072284 | Context-dependent compensation among phosphatidylserine-recognition receptors |
Q47106416 | Dietary guidance for lutein: consideration for intake recommendations is scientifically supported |
Q61447542 | Exploring the differential mechanisms of carotenoid biosynthesis in the yellow peel and red flesh of papaya |
Q49597781 | Genetic Loci Controlling Carotenoid Biosynthesis in Diverse Tropical Maize Lines. |
Q39094660 | Host-related factors explaining interindividual variability of carotenoid bioavailability and tissue concentrations in humans |
Q39533399 | Increased Macular Pigment Optical Density and Visual Acuity following Consumption of a Buttermilk Drink Containing Lutein-Enriched Egg Yolks: A Randomized, Double-Blind, Placebo-Controlled Trial |
Q30829406 | Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up |
Q57177518 | Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids |
Q92269896 | Investigating the potential of Zernike polynomials to characterise spatial distribution of macular pigment |
Q46443587 | Lack of β, β-carotene-9', 10'-oxygenase 2 leads to hepatic mitochondrial dysfunction and cellular oxidative stress in mice |
Q40703905 | Light, lipids and photoreceptor survival: live or let die? |
Q91617441 | Limited appearance of apocarotenoids is observed in plasma after consumption of tomato juices: a randomized human clinical trial |
Q38901504 | Lutein and Zeaxanthin Isomers in Eye Health and Disease |
Q30693939 | Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease |
Q38751193 | Mechanisms of selective delivery of xanthophylls to retinal pigment epithelial cells by human lipoproteins |
Q89607086 | Mechanistic understanding of β-cryptoxanthin and lycopene in cancer prevention in animal models |
Q37347216 | Molecular aspects of β, β-carotene-9', 10'-oxygenase 2 in carotenoid metabolism and diseases |
Q37592954 | Nutritional and Lifestyle Interventions for Age-Related Macular Degeneration: A Review |
Q38317289 | Nutritional supplements in age-related macular degeneration |
Q38921719 | Plasma long-chain omega-3 polyunsaturated fatty acids and macular pigment in subjects with family history of age-related macular degeneration: the Limpia Study |
Q37715993 | Potential protective function of the sterol regulatory element binding factor 1-fatty acid desaturase 1/2 axis in early-stage age-related macular degeneration |
Q35819298 | Restoration of mesenchymal retinal pigmented epithelial cells by TGFβ pathway inhibitors: implications for age-related macular degeneration |
Q49897721 | Rethinking Phagocytes: Clues from the Retina and Testes. |
Q91756849 | Review on nutritional composition of orange-fleshed sweet potato and its role in management of vitamin A deficiency |
Q38828895 | Risk factors and biomarkers of age-related macular degeneration |
Q91883858 | Single Nucleotide Polymorphisms in β-Carotene Oxygenase 1 are Associated with Plasma Lycopene Responses to a Tomato-Soy Juice Intervention in Men with Prostate Cancer |
Q36586130 | Synthesis of docosahexaenoic acid from eicosapentaenoic acid in retina neurons protects photoreceptors from oxidative stress |
Q47130133 | Targeted Metabolomics Reveals Abnormal Hepatic Energy Metabolism by Depletion of β-Carotene Oxygenase 2 in Mice |
Q58611705 | The Role of Diet, Micronutrients and the Gut Microbiota in Age-Related Macular Degeneration: New Perspectives from the Gut⁻Retina Axis |
Q35106624 | The relationship between BCMO1 gene variants and macular pigment optical density in persons with and without age-related macular degeneration |
Q59446743 | What do we know about the macular pigment in AMD: the past, the present, and the future |
Search more.